Clinical Trial Update: Pharmacokinetic Studies Participation Survey

View source ↗

Summary

This completed NCI-sponsored trial update covers participation in pharmacokinetic studies for patients with relapsed solid tumors and leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Leukemia
• Solid Tumors

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Relapsed Solid Tumors, Relapsed Leukemia | Status: COMPLETED